These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inhibitory activity and resistance to hydrolysis by beta-lactamases of some (D,L)-7-(alpha-fluoroacylamino)cephalosporins. Somma S; Malabarba A; Gastaldo L; Cavalleri B Farmaco Sci; 1984 May; 39(5):463-72. PubMed ID: 6376165 [TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology of cephalosporin antibiotics. Papich MG J Am Vet Med Assoc; 1984 Feb; 184(3):344-7. PubMed ID: 6698871 [No Abstract] [Full Text] [Related]
26. Cephalosporin group of antimicrobial drugs. Thomson TD; Quay JF; Webber JA J Am Vet Med Assoc; 1984 Nov; 185(10):1109-14. PubMed ID: 6392238 [No Abstract] [Full Text] [Related]
27. Cephapirin: clinical, pharmacological, and microbiological studies. Jameson S; McHenry MC; VanOmmen RA; Gavan TL; Vidt DG; Butler DA Del Med J; 1971 Nov; 43(11):384-90. PubMed ID: 5122252 [No Abstract] [Full Text] [Related]
28. A strategy for evaluating which of the new cephalosporins to use. Yogev R Pediatr Ann; 1986 Jun; 15(6):470-1, 474-7. PubMed ID: 3725440 [No Abstract] [Full Text] [Related]
29. beta-Lactamases and resistance to cephalosporins. Mouton RP Antonie Van Leeuwenhoek; 1981 Mar; 47(1):79. PubMed ID: 6972734 [No Abstract] [Full Text] [Related]
30. [Clinical experience with ceftazidime in the infectious disease of children]. Nagamatsu I; Horiguchi S Jpn J Antibiot; 1984 Mar; 37(3):338-43. PubMed ID: 6376846 [TBL] [Abstract][Full Text] [Related]
31. Choice of cephalosporins. Med Lett Drugs Ther; 1983 Jun; 25(637):57-60. PubMed ID: 6855695 [No Abstract] [Full Text] [Related]
32. The effect of beta-lactamases of varying origin on different types of cephalosporins. Previously announced contribution to discussion. Ericsson H Scand J Infect Dis Suppl; 1978; (13):33-4. PubMed ID: 278144 [No Abstract] [Full Text] [Related]
35. [Possibilities for the use of basic cephalosporins]. Rodloff AC; Knothe H Infection; 1993; 21 Suppl 1():S10-3. PubMed ID: 8314286 [TBL] [Abstract][Full Text] [Related]
36. Novel resistance selected by the new expanded-spectrum cephalosporins: a concern. Sanders CC J Infect Dis; 1983 Mar; 147(3):585-9. PubMed ID: 6601169 [No Abstract] [Full Text] [Related]
37. An epidemiological study of three cephalosporins: cefotetan, cefixime and cefpirome. Fabius GT; Niƫl-Weise B; Jeronimus A J Chemother; 1989 Jul; 1(4 Suppl):113-6. PubMed ID: 16312330 [No Abstract] [Full Text] [Related]
38. [Bacteriological and clinical studies on cefozopran in pediatric field]. Nishimura T; Tabuki K; Takagi M; Aoki S Jpn J Antibiot; 1994 Nov; 47(11):1544-52. PubMed ID: 7853684 [TBL] [Abstract][Full Text] [Related]
39. The cephalosporins. Thompson RL Mayo Clin Proc; 1977 Oct; 52(10):625-30. PubMed ID: 909313 [TBL] [Abstract][Full Text] [Related]
40. Third generation cephalosporins. Cunha BA; Ristuccia AM Med Clin North Am; 1982 Jan; 66(1):283-91. PubMed ID: 7038335 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]